{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:17:09Z","timestamp":1787674629828,"version":"build-2784847793"},"reference-count":105,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008678","name":"Universit\u00e4t Leipzig","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008678","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p><jats:italic>Cryptococcus neoformans<\/jats:italic>, an opportunistic fungal pathogen ubiquitously present in the environment, causes cryptococcal meningitis (CM) mainly in immunocompromised patients, such as AIDS patients. We aimed to identify disease-associated cryptococcal protein antigens targeted by the human humoral immune response. Therefore, we used sera from Colombian CM patients, with or without HIV infection, and from healthy individuals living in the same region. Serological analysis revealed increased titers of anti-cryptococcal IgG in HIV-negative CM patients, but not HIV-positive CM patients, compared to healthy controls. In contrast, titers of anti-cryptococcal IgM were not affected by CM. Furthermore, we detected pre-existing IgG and IgM antibodies even in sera from healthy individuals. The observed induction of anti-cryptococcal IgG but not IgM during CM was supported by analysis of sera from<jats:italic>C. neoformans<\/jats:italic>-infected mice. Stronger increase in IgG was found in wild type mice with high lung fungal burden compared to IL-4R\u03b1-deficient mice showing low lung fungal burden. To identify the proteins targeted by human anti-cryptococcal IgG antibodies, we applied a quantitative 2D immunoproteome approach identifying cryptococcal protein spots preferentially recognized by sera from CM patients or healthy individuals followed by mass spectrometry analysis. Twenty-three cryptococcal proteins were recombinantly expressed and confirmed to be immunoreactive with human sera. Fourteen of them were newly described as immunoreactive proteins. Twelve proteins were classified as disease-associated antigens, based on significantly stronger immunoreactivity with sera from CM patients compared to healthy individuals. The proteins identified in our screen significantly expand the pool of cryptococcal proteins with potential for (i) development of novel anti-cryptococcal agents based on implications in cryptococcal virulence or survival, or (ii) development of an anti-cryptococcal vaccine, as several candidates lack homology to human proteins and are localized extracellularly. Furthermore, this study defines pre-existing anti-cryptococcal immunoreactivity in healthy individuals at a molecular level, identifying target antigens recognized by sera from healthy control persons.<\/jats:p>","DOI":"10.3389\/fimmu.2021.709695","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T08:15:06Z","timestamp":1627028106000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Identification of Disease-Associated Cryptococcal Proteins Reactive With Serum IgG From Cryptococcal Meningitis Patients"],"prefix":"10.3389","volume":"12","author":[{"given":"A. Elisabeth","family":"Gressler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Volke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Firacative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane L.","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andor","family":"Krizsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Schulze-Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Brock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Brombacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Escand\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gottfried","family":"Alber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a019760","article-title":"Cryptococcus neoformans and Cryptococcus gattii, the Etiologic Agents of Cryptococcosis","volume":"4","author":"Kwon-Chung","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B2","article-title":"Pathogenesis of Cryptococcosis in Humans","volume-title":"Human Emerging and Re-emerging Infections: Bacterial & Mycotic Infections","author":"Negroni","year":"2016"},{"key":"B3","first-page":"56","article-title":"Isolation of Cryptococcus neoformans and Other Opportunistic Fungi From Pigeon Droppings","volume":"18","author":"Soltani","year":"2013","journal-title":"J Res Med Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3906\/sag-0808-10","article-title":"Isolation of Cryptococcus neoformans From Pigeon Droppings in Ahwaz, Iran","volume":"40","author":"Zarrin","year":"2010","journal-title":"Turk J Med Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8050682","article-title":"Indoor Dust as a Source of Virulent Strains of the Agents of Cryptococcosis in the Rio Negro Micro-Region of the Brazilian Amazon","volume":"8","author":"Brito-Santos","year":"2020","journal-title":"Microorganisms"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/mmy.38.5.379.383","article-title":"Possible Primary Ecological Niche of Cryptococcus neoformans","volume":"38","author":"Lazera","year":"2000","journal-title":"Med Mycol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1590\/S1678-9946201759013","article-title":"The Epidemiology of Cryptococcosis and the Characterization of Cryptococcus neoformans Isolated in a Brazilian University Hospital","volume":"59","author":"Aguiar","year":"2017","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S38850","article-title":"Cryptococcal Meningitis: Epidemiology and Therapeutic Options","volume":"6","author":"Sloan","year":"2014","journal-title":"Clin Epidemiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2020.101034","article-title":"Disseminated Cryptococcosis in an Immunocompetent Patient","volume":"30","author":"Bollam","year":"2020","journal-title":"Respir Med Case Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e1004884","DOI":"10.1371\/journal.ppat.1004884","article-title":"Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis","volume":"11","author":"Panackal","year":"2015","journal-title":"PloS Pathog"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90388-3","article-title":"Disseminated Cryptococcal Infection in a Patient With Hypogammaglobulinemia and Normal T Cell Functions","volume":"82","author":"Gupta","year":"1987","journal-title":"Am J Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/ped.13741","article-title":"Disseminated Cryptococcosis With Immunoglobulin G Subclass Deficiency","volume":"61","author":"Kaushik","year":"2019","journal-title":"Pediatr Int"},{"key":"B13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12883-020-01741-0","article-title":"Cryptococcal Meningoencephalitis in an IgG2-Deficient Patient With Multiple Sclerosis on Fingolimod Therapy for More Than Five Years - Case Report","volume":"20","author":"Wienemann","year":"2020","journal-title":"BMC Neurol"},{"key":"B14","article-title":"Bruton\u2019s Agammaglobulinaemia in a Child Presenting With Cryptococcal Empyema Thoracis and Periauricular Pyogenic Abscess","volume":"36","author":"Wahab","year":"1995","journal-title":"Singapore Med J"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199401000-00020","article-title":"Disseminated Lymphonodular Cryptococcosis in a Child With X-Linked hyper-IgM Immunodeficiency","volume":"13","author":"Tabone","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/00365540510036570","article-title":"Cryptococcal Meningitis in a Patient With X-Linked Hyper-IgM1 Syndrome","volume":"37","author":"G\u00f3rgolas","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1186\/s12879-016-1964-6","article-title":"Characteristics and Outcomes of Cryptococcal Meningitis in HIV Seronegative Children in Beijing, China, 2002-2013","volume":"16","author":"Guo","year":"2016","journal-title":"BMC Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2002.17.1.116","article-title":"X-Linked Hyper-IgM Syndrome Associated With Cryptosporidium parvum and Cryptococcus neoformans Infections: The First Case With Molecular Diagnosis in Korea","volume":"17","author":"Jo","year":"2002","journal-title":"J Korean Med Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx255","article-title":"Antibody and B Cell Subset Perturbations in Human Immunodeficiency Virus-Uninfected Patients With Cryptococcosis","volume":"5","author":"Rohatgi","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global Burden of Disease of HIV-associated Cryptococcal Meningitis: An Updated Analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000484","article-title":"Cryptococcal Antigen Screening and Early Antifungal Treamtent to Prevent Cryptococcal Meningitis: A Review of the Literature","volume":"68","author":"Kaplan","year":"2015","journal-title":"J Acq Imm Def"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1710922","article-title":"Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa","volume":"378","author":"Molloy","year":"2018","journal-title":"N Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S1473-3099(17)30442-5","article-title":"Immunotherapeutic Approaches to Treatment of Fungal Diseases","volume":"17","author":"Armstrong-James","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b19-00841","article-title":"Vaccines and Protective Immune Memory Against Cryptococcosis","volume":"43","author":"Ueno","year":"2020","journal-title":"Biol Pharm Bull"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019711","article-title":"Fungal Vaccines and Immunotherapeutics","volume":"4","author":"Santos","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41541-021-00294-8","article-title":"Vaccines for Human Fungal Diseases: Close But Still a Long Way to Go","volume":"6","author":"Oliveira","year":"2021","journal-title":"NPJ Vaccines"},{"key":"B27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.fgb.2014.11.006","article-title":"Immunity to Cryptococcus neoformans and C. gattii During Cryptococcosis","volume":"78","author":"Gibson","year":"2015","journal-title":"Fungal Genet Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.14.132","article-title":"Host Immunity to Cryptococcus neoformans","volume":"10","author":"Rohatgi","year":"2015","journal-title":"Future Microbiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s40475-019-00174-1","article-title":"Antibody Immunity and Natural Resistance to Cryptococcosis","volume":"6","author":"Trevijano-Contador","year":"2019","journal-title":"Curr Trop Med Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/jof3040064","article-title":"Adaptive Immunity to Cryptococcus neoformans Infections","volume":"3","author":"Mukaremera","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00265-13","article-title":"X-Linked Immunodeficient Mice Exhibit Enhanced Susceptibility to Cryptococcus neoformans Infection","volume":"4","author":"Szymczak","year":"2013","journal-title":"mBio"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/iai.47.1.282-287.1985","article-title":"Genetic Resistance to Murine Cryptococcosis: Increased Susceptibility in the CBA\/N Xid Mutant Strain of Mice","volume":"47","author":"Marquis","year":"1985","journal-title":"Infect Immun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901638","article-title":"The Absence of Serum IgM Enhances the Susceptibility of Mice to Pulmonary Challenge With Cryptococcus neoformans","volume":"184","author":"Subramaniam","year":"2010","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.9.3446-3450.1996","article-title":"Opsonization of Cryptococcus neoformans by Human Anticryptococcal Glucuronoxylomannan Antibodies","volume":"64","author":"Zhong","year":"1996","journal-title":"Infect Immun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.12.7049-7060.2000","article-title":"Human Antibodies Against a Purified Glucosylceramide From Cryptococcus neoformans Inhibit Cell Budding and Fungal Growth","volume":"68","author":"Rodrigues","year":"2000","journal-title":"Infect Immun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/iai.51.2.556-562.1986","article-title":"Antibody-Dependent Natural Killer Cell-Mediated Growth Inhibition of Cryptococcus neoformans","volume":"51","author":"Nabavi","year":"1986","journal-title":"Infect Immun"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1128\/iai.70.6.2812-2819.2002","article-title":"Fc-Dependent and Fc-Independent Opsonization of Cryptococcus neoformans by Anticapsular Monoclonal Antibodies: Importance of Epitope Specificity","volume":"70","author":"Netski","year":"2002","journal-title":"Infect Immun"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.2.573-579.1995","article-title":"Antibodies to Cryptococcus neoformans Glucuronoxylomannan Enhance Antifungal Activity of Murine Macrophages","volume":"63","author":"Mukherjee","year":"1995","journal-title":"Infect Immun"},{"key":"B39","article-title":"Role of IgG and Complement Component C5 in the Initial Course of Experimental Cryptococcosis","volume":"78","author":"Dromer","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/107.3.406","article-title":"Specific Degradation of Cryptococcus neoformans 3723 Capsular Polysaccharide by a Microbial Enzyme: III. Antibody Stimulation by Partially Decapsulated Cells","volume":"107","author":"Gadebusch","year":"1960","journal-title":"J Infect Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/199710a0","article-title":"Immunization Against Cryptococcus neoformans by Capsular Polysaccharide","volume":"199","author":"Gadebusch","year":"1963","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)00256-Z","article-title":"Preclinical Efficacy of a Glucuronoxylomannan-Tetanus Toxoid Conjugate Vaccine of Cryptococcus neoformans in a Murine Model","volume":"14","author":"Devi","year":"1996","journal-title":"Vaccine"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.2.1087","article-title":"A Cryptococcal Capsular Polysaccharide Mimotope Prolongs the Survival of Mice With Cryptococcus neoformans Infection","volume":"166","author":"Fleuridor","year":"2001","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1128\/iai.72.1.196-208.2004","article-title":"Immunogenicity and Efficacy of Cryptococcus neoformans Capsular Polysaccharide Glucuronoxylomannan Peptide Mimotope-Protein Conjugates in Human Immunoglobulin Transgenic Mice","volume":"72","author":"Maitta","year":"2004","journal-title":"Infect Immun"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201300213","article-title":"Identification and Characterization of Cryptococcus neoformans Protein Fractions That Induce Protective Immune Responses","volume":"13","author":"Chaturvedi","year":"2013","journal-title":"Proteomics"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e104316","DOI":"10.1371\/journal.pone.0104316","article-title":"Vaccine-Mediated Immune Responses to Experimental Pulmonary Cryptococcus gattii Infection in Mice","volume":"9","author":"Chaturvedi","year":"2014","journal-title":"PloS One"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3109\/00365548809032452","article-title":"Cryptococcus neoformans Antibody Levels in Patients With AIDS","volume":"20","author":"Dromer","year":"1988","journal-title":"Scand J Infect Dis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.7.2857-2864.1994","article-title":"Occurences, Immunoglobulin Classes, and Biological Activities of Antibodies in Normal Human Serum That Are Reactive With Cryptococcus neoformans Glucuronoxylomannan","volume":"62","author":"Houpt","year":"1994","journal-title":"Infect Immun"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1995.tb05568.x","article-title":"Antibodies to the Cryptococcus neoformans Capsular Glucuronoxylomannan are Ubiquitous in Serum From HIV+ and HIV\u2013 Individuals","volume":"99","author":"Deshaw","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/0888-0786(96)87297-0","article-title":"Anti-Cryptococcus neoformans Antibodies During Cryptococcosis in Patients With the Acquired Immunodeficiency Syndrome","volume":"7","author":"Dromer","year":"1995","journal-title":"Serodiag Immun Inf D"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1086\/314953","article-title":"Antibodies Reactive With the Cryptococcal Capsular Polysaccharide Glucuronoxylomannan Are Present in Sera From Children With and Without Human Immunodeficiency Virus Infection","volume":"180","author":"Abadi","year":"1999","journal-title":"J Infect Dis"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1086\/315102","article-title":"Quantitative and Qualitative Differences in the Serum Antibody Profiles of Human Immunodeficiency Virus-Infected Persons With and Without Cryptococcus neoformans Meningitis","volume":"180","author":"Fleuridor","year":"1999","journal-title":"J Infect Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.12.10.1168-1176.2005","article-title":"Cryptococcus neoformans-Reactive and Total Immunoglobulin Profiles of Human Immunodeficiency Virus-Infected and Uninfected Ugandans","volume":"12","author":"Subramaniam","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00139-06","article-title":"Antibody Response to Cryptococcus neoformans Capsular Polysaccharide Glucuronoxylomannan in Patients After Solid-Organ Transplantation","volume":"13","author":"Jalali","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1086\/599318","article-title":"IgM(+) Memory B Cell Expression Predicts HIV-associated Cryptococcosis Status","volume":"200","author":"Subramaniam","year":"2009","journal-title":"J Infect Dis"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00573-13","article-title":"Fc Gamma Receptor 3A Polymorphism and Risk for HIV-associated Cryptococcal Disease","volume":"4","author":"Rohatgi","year":"2013","journal-title":"mBio"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2003.02181.x","article-title":"Humoral Response Against Cryptococcus neoformans Mannoprotein Antigens in HIV-Infected Patients","volume":"133","author":"Pitzurra","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.5.2218-2224.1999","article-title":"Antibody Response to Cryptococcus neoformans Proteins in Rodents and Humans","volume":"67","author":"Chen","year":"1999","journal-title":"Infect Immun"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.107.5.e66","article-title":"Goldman Et al. - 2001 - Serologic Evidence for Cryptococcus neoformans Inf","volume":"107","author":"Goldman","year":"2001","journal-title":"Pediatrics"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318047e073","article-title":"Serologic Evidence for Regional Differences in Pediatric Cryptococcal Infection","volume":"26","author":"Davis","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1080\/13693780801961345","article-title":"Antibody Responses to Cryptococcus neoformans in Indian Patients With Cryptococcosis","volume":"46","author":"Saha","year":"2008","journal-title":"Med Mycol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2008.01549.x","article-title":"Detection of IgM and IgG Antibodies to Cryptococcus neoformans Proteins in Blood Donors and HIV Patients With Active Cryptococcosis","volume":"52","author":"Chai","year":"2009","journal-title":"Mycoses"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200800713","article-title":"A Proteomic-Based Approach for the Identification of Immunodominant Cryptococcus neoformans Proteins","volume":"9","author":"Young","year":"2009","journal-title":"Proteomics"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1038\/s41598-018-21039-z","article-title":"Identification of T Helper (Th)1- and Th2-associated Antigens of Cryptococcus neoformans in a Murine Model of Pulmonary Infection","volume":"8","author":"Firacative","year":"2018","journal-title":"Sci Rep"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1021\/pr100028t","article-title":"Immunoproteomic Approach to Elucidating the Pathogenesis of Cryptococcosis Caused by Cryptococcus gattii","volume":"9","author":"Jobbins","year":"2010","journal-title":"J Proteome Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.13.22","article-title":"Immunoproteomics and Immunoinformatics Analysis of Cryptococcus gattii Novel Candidate Antigens for Diagnosis","volume":"8","author":"Martins","year":"2013","journal-title":"Future Microbiol"},{"key":"B67","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.162.12.7302","article-title":"Differences Between Il-4- and IL-4 Receptor a-Deficient Mice in Chronic Leishmaniasis Reveal a Protective Role for IL-13 Receptor Signaling","volume":"162","author":"Mohrs","year":"1999","journal-title":"J Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.8.5367","article-title":"Il-13 Induces Disease-Promoting Type 2 Cytokines, Alternatively Activated Macrophages and Allergic Inflammation During Pulmonary Infection of Mice With Cryptococcus neoformans","volume":"179","author":"M\u00fcller","year":"2007","journal-title":"J Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1021\/ac60111a017","article-title":"Colorimetric Method for Determination of Sugars and Related Substances","volume":"28","author":"DuBois","year":"1956","journal-title":"Anal Chem"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10030369","article-title":"A Workflow Towards the Reproducible Identification and Quantitation of Protein Carbonylation Sites in Human Plasma","volume":"10","author":"Rojas Echeverri","year":"2021","journal-title":"Antioxid (Basel)"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2018.10.021","article-title":"Cross-Chemistry Leads to Product Diversity From Atromentin Synthetases in Aspergilli From Section Nigri","volume":"26","author":"Geib","year":"2019","journal-title":"Cell Chem Biol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00362-09","article-title":"Aspergillus fumigatus Catalytic Glucokinase and Hexokinase: Expression Analysis and Importance for Germination, Growth, and Conidiation","volume":"9","author":"Fleck","year":"2010","journal-title":"Eukaryot Cell"},{"key":"B73","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40694-017-0042-1","article-title":"ATNT: An Enhanced System for Expression of Polycistronic Secondary Metabolite Gene Clusters in Aspergillus niger","volume":"4","author":"Geib","year":"2017","journal-title":"Fungal Biol Biotechnol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myv024","article-title":"Analysis of Asthma Patients for Cryptococcal Seroreactivity in an Urban German Area","volume":"53","author":"Grahnert","year":"2015","journal-title":"Med Mycol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1086\/593068","article-title":"A Gene-Dosage Effect for Interleukin-4 Receptor Alpha-Chain Expression has an Impact on Th2-Mediated Allergic Inflammation During Bronchopulmonary Mycosis","volume":"198","author":"M\u00fcller","year":"2008","journal-title":"J Infect Dis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1128\/EC.00370-07","article-title":"Extracellular Vesicles Produced by Cryptococcus neoformans Contain Protein Components Associated With Virulence","volume":"7","author":"Rodrigues","year":"2008","journal-title":"Eukaryot Cell"},{"key":"B77","article-title":"Relationship of Serum Immunoglobulin and IgG Subclass Levels to Race, Ethnicity and Behavioral Characteristics in HIV Infection","volume":"12","author":"McGowan","year":"2006","journal-title":"Med Sci Monit"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/j.0300-9475.2004.01376.x","article-title":"Immunoglobulin Levels Amongst Persons With and Without Human Immunodeficiency Virus Type 1 Infection in Uganda and Norway","volume":"59","author":"Lugada","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115621","article-title":"Human Immunodeficiency Virus Infection Induces Both Polyclonal and Virus-Specific B Cell Activation","volume":"89","author":"Shirai","year":"1992","journal-title":"J Clin Invest"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1084\/jem.174.1.151","article-title":"The Mouse Antibody Response to Infection With Cryptococcus neoformans: VH and VL Usage in Polysaccharide Binding Antibodies","volume":"174","author":"Casadevall","year":"1991","journal-title":"J Exp Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.10.3204-3209.1999","article-title":"Epidemiological Evidence for Dormant Cryptococcus neoformans Infection","volume":"37","author":"Garcia-Hermoso","year":"1999","journal-title":"J Clin Microbiol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3109\/13693780903300319","article-title":"Activated Dormant Cryptococcus gattii Infection in a Dutch Tourist Who Visited Vancouver Island (Canada): A Molecular Epidemiological Approach","volume":"48","author":"Hagen","year":"2010","journal-title":"Med Mycol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2011.00171","article-title":"Fungal Polysaccharides: Biological Activity Beyond the Usual Structural Properties","volume":"2","author":"Rodrigues","year":"2011","journal-title":"Front Microbiol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/nri3684","article-title":"The Mycobiota: Interactions Between Commensal Fungi and the Host Immune System","volume":"14","author":"Underhill","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2017.1370529","article-title":"Na\u00efve B Cells Reduce Fungal Dissemination in Cryptococcus neoformans Infected Rag1-\/- Mice","volume":"9","author":"Dufaud","year":"2018","journal-title":"Virulence"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01872-17","article-title":"Vaccination With Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice Against Cryptococcosis in a Manner Dependent Upon Mouse Strain and Cryptococcal Species","volume":"8","author":"Specht","year":"2017","journal-title":"mBio"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.10.051","article-title":"Protection of Mice Against Experimental Cryptococcosis Using Glucan Particle-Based Vaccines Containing Novel Recombinant Antigens","volume":"38","author":"Hester","year":"2020","journal-title":"Vaccine"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01101-14","article-title":"Invasion of the Central Nervous System by Cryptococcus neoformans Requires a Secreted Fungal Metalloprotease","volume":"5","author":"Vu","year":"2014","journal-title":"mBio"},{"key":"B89","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1567-1364.2006.00198.x","article-title":"Extracellular Glycosylphosphatidylinositol-Anchored Mannoproteins and Proteases of Cryptococcus neoformans","volume":"7","author":"Eigenheer","year":"2007","journal-title":"FEMS Yeast Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01249-20","article-title":"An Antivirulence Approach for Preventing Cryptococcus neoformans From Crossing the Blood-Brain Barrier Via Novel Natural Product Inhibitors of a Fungal Metalloprotease","volume":"11","author":"Aaron","year":"2020","journal-title":"mBio"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00220-13","article-title":"Factors Required for Activation of Urease as a Virulence Determinant in Cryptococcus neoformans","volume":"4","author":"Singh","year":"2013","journal-title":"mBio"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e1004062","DOI":"10.1371\/journal.ppat.1004062.g001","article-title":"The Emerging Role of Urease as a General Microbial Virulence Factor","volume":"10","author":"Rutherford","year":"2014","journal-title":"PloS Pathog"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00103-15","article-title":"Virulence-Associated Enzymes of Cryptococcus neoformans","volume":"14","author":"Almeida","year":"2015","journal-title":"Eukaryot Cell"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3314\/mmj.18-00001","article-title":"Identification of Heparin-Binding Proteins on the Cell Surface of Cryptococcus neoformans","volume":"59","author":"Ikeda","year":"2018","journal-title":"Med Mycol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"e5780","DOI":"10.1371\/journal.pone.0005780","article-title":"Surface-Associated Plasminogen Binding of Cryptococcus neoformans Promotes Extracellular Matrix Invasion","volume":"4","author":"Stie","year":"2009","journal-title":"PloS One"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1128\/EC.5.3.518-529.2006","article-title":"Posttranslational, Translational, and Transcriptional Responses to Nitric Oxide Stress in Cryptococcus neoformans: Implications for Virulence","volume":"5","author":"Missall","year":"2006","journal-title":"Eukaryot Cell"},{"key":"B97","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1021\/pr2005296","article-title":"Proteomic Profiling of the Influence of Iron Availability on Cryptococcus gattii","volume":"11","author":"Crestani","year":"2012","journal-title":"J Proteome Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-147-7-1961","article-title":"Overexpression of a Dominant-Negative Allele of YPT1 Inhibits Growth and Aspartyl Protease Secretion in Candida albicans","volume":"147","author":"Lee","year":"2001","journal-title":"Microbiology"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(88)90433-3","article-title":"The Yeast Gtp-Binding YPT1 Protein and a Mammalian Counterpart Are Associated With the Secretion Machinery","volume":"52","author":"Segev","year":"1988","journal-title":"Cell"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.109.3.1015","article-title":"The GTP-binding Protein YPT1 Is Required for Transport in Vitro: The Golgi Apparatus Is Defective in Ypt1 Mutants","volume":"109","author":"Bacon","year":"1989","journal-title":"J Cell Biol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.7.7.2367","article-title":"The Ras-Like Yeast Ypt1 Gene is Itself Essential for Growth, Sporulation, and Starvation Response","volume":"7","author":"Segev","year":"1987","journal-title":"Mol Cell Biol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.00821.x","article-title":"Heat Shock Protein 70 (hsp70) as a Major Target of the Antibody Response in Patients With Pulmonary Cryptococcosis","volume":"115","author":"Kakeya","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.5.1653-1658.1997","article-title":"A 77-Kilodalton Protein of Cryptococcus neoformans, a Member of the Heat Shock Protein 70 Family, is a Major Antigen Detected in the Sera of Mice With Pulmonary Cryptococcosis","volume":"5","author":"Kakeya","year":"1997","journal-title":"Infect Immun"},{"key":"B104","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.fgb.2013.08.005","article-title":"The Heat Shock Protein (Hsp) 70 of Cryptococcus neoformans Is Associated With the Fungal Cell Surface and Influences the Interaction Between Yeast and Host Cells","volume":"60","author":"Silveira","year":"2013","journal-title":"Fungal Genet Biol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"5999","DOI":"10.4049\/jimmunol.1402719","article-title":"Cryptococcal Heat Shock Protein 70 Homolog Ssa1 Contributes to Pulmonary Expansion of Cryptococcus neoformans During the Afferent Phase of the Immune Response by Promoting Macrophage M2 Polarization","volume":"194","author":"Eastman","year":"2015","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.709695\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T07:26:48Z","timestamp":1672903608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.709695\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,23]]},"references-count":105,"alternative-id":["10.3389\/fimmu.2021.709695"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.709695","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,23]]},"article-number":"709695"}}